Funded Studies

Study Rationale: Parkinson's disease (PD) is characterized by the death of dopamine neurons, which control movement. We have generated a novel therapeutic agent — an antibody that activates a receptor...

Study Rationale: Early indicators for Parkinson’s disease (PD), so-called biomarkers, are needed to identify subjects at risk during the earliest, prodromal stages of disease and to support clinical...

Study Rationale: To evaluate treatments in ways that are meaningful to people with Parkinson’s disease (PD), we need to identify measurements that reflect how people with early PD function and feel...

Study Rationale: Non-pharmacological interventions can benefit human health, and anecdotal evidence suggest that people with Parkinson’s disease (PD) show fewer symptoms when traveling at high...

Study Rationale: Parkinson’s disease (PD) has long been associated with mitochondrial dysfunction. Perturbation of these subcellular structures can lead to the release of reactive oxygen species (ROS)...

Study Rationale: As new treatments for Parkinson's disease (PD) are developed, it is important to determine how they might affect the health and finances of people with PD, their families and society...